Cormorant Asset Management, LP

Investment Portfolio & 13F Holdings Analysis

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
42
Total Value
1218119015
Accession Number
0001583977-25-000005
Form Type
13F-HR
Manager Name
Cormorant-Asset-Management-Lp
Data Enrichment
88% identified
37 identified5 unidentified

Holdings

42 positions
Manager:
Search and click to pin securities to the top
Page 1 of 3
MoonLake Immunotherapeutics
Shares:8.5M
Value:$331.9M
Edgewise Therapeutics, Inc.
Shares:4.1M
Value:$90.2M
BridgeBio Pharma, Inc.
Shares:2.0M
Value:$69.1M
Arcellx, Inc.
Shares:1.1M
Value:$68.9M
Praxis Precision Medicines, Inc.
Shares:1.7M
Value:$66.1M
EyePoint Pharmaceuticals, Inc.
Shares:8.3M
Value:$45.1M
INSMED Inc
Shares:525.0K
Value:$40.1M
10919W405
Shares:1.1M
Value:$38.2M
G4444H101
Shares:2.9M
Value:$32.9M
Centessa Pharmaceuticals plc
Shares:2.3M
Value:$32.5M
Merus N.V.
Shares:740.0K
Value:$31.1M
Rapport Therapeutics, Inc.
Shares:2.9M
Value:$29.5M
Axsome Therapeutics, Inc.
Shares:250.0K
Value:$29.2M
Pharvaris N.V.
Shares:1.5M
Value:$23.0M
GH Research PLC
Shares:2.0M
Value:$22.2M
Arcutis Biotherapeutics, Inc.
Shares:1.4M
Value:$21.1M
Tarsus Pharmaceuticals, Inc.
Shares:400.0K
Value:$20.5M
ARS Pharmaceuticals, Inc.
Shares:1.6M
Value:$20.1M
Crinetics Pharmaceuticals, Inc.
Shares:600.0K
Value:$20.1M
CG Oncology, Inc.
Shares:775.0K
Value:$19.0M